Nerve growth factor (NGF) has an anti-tumor effects through perivascular innervation of neovessels in HT1080 fibrosarcoma and HepG2 hepatitis tumor in nude mice

This study investigated whether NGF prevents tumor growth by promoting neuronal regulation of tumor blood flow. HT1080 fibrosarcoma cells or HepG2 hepatitis cells were subcutaneously implanted into nude mice. On Day 21 after the implantation of tumor cells, human NGF (40 or 80 ng/h for 14 days) was...

Full description

Saved in:
Bibliographic Details
Main Authors: Hiromu Kawasaki (Author), Mitsuhiro Goda (Author), Satoko Fukuhara (Author), Narumi Hashikawa-Hobara (Author), Yoshito Zamami (Author), Shingo Takatori (Author)
Format: Book
Published: Elsevier, 2019-05-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_33d52bc065c94a938a871dba238c4c00
042 |a dc 
100 1 0 |a Hiromu Kawasaki  |e author 
700 1 0 |a Mitsuhiro Goda  |e author 
700 1 0 |a Satoko Fukuhara  |e author 
700 1 0 |a Narumi Hashikawa-Hobara  |e author 
700 1 0 |a Yoshito Zamami  |e author 
700 1 0 |a Shingo Takatori  |e author 
245 0 0 |a Nerve growth factor (NGF) has an anti-tumor effects through perivascular innervation of neovessels in HT1080 fibrosarcoma and HepG2 hepatitis tumor in nude mice 
260 |b Elsevier,   |c 2019-05-01T00:00:00Z. 
500 |a 1347-8613 
500 |a 10.1016/j.jphs.2019.02.011 
520 |a This study investigated whether NGF prevents tumor growth by promoting neuronal regulation of tumor blood flow. HT1080 fibrosarcoma cells or HepG2 hepatitis cells were subcutaneously implanted into nude mice. On Day 21 after the implantation of tumor cells, human NGF (40 or 80 ng/h for 14 days) was administered using a micro-osmotic pump. Growth rates of both tumors were significantly inhibited by the treatment of NGF, and the survival rate was also extended. Significant suppression of HT1080 tumor growth lasted after withdrawing NGF. NGF markedly increased the density of α-smooth muscle actin (α-SMA)-immunoreactive (ir) cells without changing neovessel density in HT1080 tumor tissues. Double immunostaining demonstrated protein gene product (PGP) 9.5-ir nerves around α-SMA-ir cells were found in HT1080 tumor tissue treated with NGF. The blood flow in HepG2 tumors treated with saline was significantly higher than in the non-tumor control area, but the tumor blood flow was markedly reduced by NGF treatment. In in vitro studies, NGF significantly accelerated migration of aortic smooth muscle cells but not endothelial cells, whereas NGF had no cytotoxic action on both cells. NGF inhibits tumor growth via indirect action, probably through innervation and maturation of tumor neovasculature, which regulates blood flow into tumor tissues. Keywords: Nerve growth factor, Tumor growth inhibition, HT1080 fibrosarcoma cell, HepG2 hepatitis cell, Perivascular innervation 
546 |a EN 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Journal of Pharmacological Sciences, Vol 140, Iss 1, Pp 1-7 (2019) 
787 0 |n http://www.sciencedirect.com/science/article/pii/S1347861319310485 
787 0 |n https://doaj.org/toc/1347-8613 
856 4 1 |u https://doaj.org/article/33d52bc065c94a938a871dba238c4c00  |z Connect to this object online.